Thus, efforts should be made to understand the inhibitory mechanisms of NGI-1, as well as the precise functions of accessory subunits of OST in N-glycosylation and tumor progression, which will accelerate structure-based drug design and discovery. The gene discussed is DDOST; the disease is neoplasm.